The Department of Health and Human Services (DHHS) is the U.S. federal government agency responsible for protecting the health of the American public.

The DHHS HIV guidelines help inform healthcare professionals of the best ways to treat HIV based on the latest clinical evidence and expert opinions.

In this article, we break down some of the key points of the DHHS guidelines and what to know about the most recent changes.

The main goal of the DHHS guidelines is to offer recommendations to healthcare professionals on the best treatment options for people with HIV. The guidelines are written and updated based on the most recent scientific evidence.

Doctors can consult these guidelines to determine the right treatment at various stages of HIV. For example, the guidelines provide recommendations on when to start antiretroviral therapy (ART), which drugs should be used, and what to do if initial treatment isnt working.

The full guidelines provide a long list of recommendations you can read here. Weve summarized some key points below so you can get an idea of the type of information these guidelines include.

Initial HIV treatment generally consists of two medications called nucleoside reverse transcriptase inhibitors in combination with a third active antiretroviral (ARV) drug from one of three drug classes:

The following drug regimens are classified as recommended initial regimens for most people with HIV. A slash (/) between medications means theyre available as a combination drug within the same pill:

When ART isnt working, several factors should be considered, including:

At the time this article was written, the DHHS guidelines were most recently updated on June 3, 2021.

Researchers are continuing to improve their understanding of how to best treat and manage HIV. The guidelines are updated periodically to include the latest research and expert opinions.

Heres an overview of the most recent changes included in the 2021 update.

New evidence from the Botswana Tsepamo Study, an ongoing observational study that started in 2014, suggests that the rate of neural tube defects (a type of structural change in a developing fetus) is lower than expected in women taking dolutegravir at the time of conception.

Dolutegravir is now recommended as an initial treatment option for people who may get pregnant.

The medication raltegravir was moved from recommended initial regimens for most people with HIV to recommended initial regimen in certain clinical situations.

The change was partially made due to the results of the Botswana Tsepamo Study. Since dolutegravir is now a viable treatment for people who can get pregnant, its no longer necessary to choose raltegravir over dolutegravir.

It was initially recommended that if ART treatment doesnt work, it should be followed by two and preferably three fully active ARV drugs.

Its now recommended that the new treatment can include two fully active drugs if at least one has a high resistance barrier. Examples of such drugs include boosted darunavir or dolutegravir. The change was made based on the results of ongoing clinical trials.

Updates include the mechanism behind declining CD4 counts despite suppressive ART.

CD4 cells are a type of white blood that fights infections. Knowing a persons CD4 count helps determine their risk of developing opportunistic infections.

The new guidelines also include updated strategies to reduce persistent inflammation.

Updates include the role of long-acting injectable regimens cabotegravir plus rilpivirine. Long-acting injectables are a new form of ART that involve infrequent injections instead of daily oral medication.

The Food and Drug Administration (FDA) approved the first long-acting injectable for treating HIV in January 2021.

The adolescent and young adults section has been updated to include current data on the rate of HIV among youth in the United States.

The guidelines now also have more details on the unique challenges that youth with HIV face compared to adults.

This section now includes data from a 2020 review of eight studies that found that women are more likely to gain weight than men after starting ART.

Theres also now more information regarding the effects of menopause and hormone replacement therapy while on HIV treatment.

This section now includes information about when to consider the long-acting injectable cabotegravir plus rilpivirine in people with a substance use disorder.

Current research is limited to people with good medication adherence.

Newly discovered drug interactions have been included in the guidelines, including interactions between the drugs cabotegravir plus rilpivirine and fostemsavir.

A section was added discussing the cost effectiveness of new drugs, such as ibalizumab, in HIV thats resistant to multiple ARV drugs.

Monthly prices of commonly prescribed ARV drugs have been updated with 2021 prices.

Updates describe current recommendations for ARV drugs that can be used if 3 months of isoniazid and rifapentine are prescribed for tuberculosis.

There are many free or low-cost programs available to help people with HIV. Here are some resources that may be helpful:

The DDHS HIV guidelines were developed to help healthcare professionals stay up to date with the latest HIV research so they can provide the best possible treatment. The guidelines are updated regularly as new research or evidence becomes available.

The guidelines are available online for free to anybody who wants to read them.

Original post:
Overview of the Latest DHHS HIV Treatment Guidelines - Healthline

Global Hormone Replacement Therapy Market Technology Prospectus to 2027 Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals, Bayer AG The latest report published by Zion Market Research provides the present and future growth prospects for the globalHormone Replacement Therapy Marketby a thorough understanding of the factors that are shaping the trends that are further driving the growth of the market in terms of region & segment, untapped market places, and revenue potential with the consumption pattern and demand of the product. Every section of the report is scoped with an in-depth analysis of the market and represented in a systematic data analysis framework for the forecast period of 2020-2026 for a better understanding of the market. The report on the global Hormone Replacement Therapy Market also incorporates the impact of the Covid-19 pandemic including the factors that have affected the market growth that will allow the investor to invest wisely as per the current trends to stay ahead in the market.

FREE | Request Sample is Available @https://www.zionmarketresearch.com/sample/hormone-replacement-therapy-market

The global Hormone Replacement Therapy Market is anticipated to reach the market size of xx million USD in 2026 from xx million USD in 2020 by registering a CAGR value of xx %.

The global data in the report on the global Hormone Replacement Therapy Market is categorized by key players [Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals, Bayer AG, Merck & co., and QuatRx Pharmaceuticals.], segments and its sub-segments and regionsEurope, Asia Pacific, Latin America, North America, and the Middle East & Africa. It also encompasses the future trends, market share, growth rate, and market status for the forecast period of 2020-2026. Porters Five, SWOT Analysis, and supply chain analysis are the analytical tools used to represent the market data in the report. Accurate calculations and estimations are provided in the report in terms of volume and value for the segment and regional growth.

Promising Regions & Countries Mentioned In The Keyword Report:

The report focuses on a detailed analysis of major market players that are functioning in the market to study the market sales, value, and share. Top revenue-generating key manufacturers are involved in the report. Further, a systemic evaluation of drivers, restraints, and opportunities are framed in the report that will allow the user to make effective business strategies to streamline the business and hold the topmost position in the market.

Request Free research report Brochure @https://www.zionmarketresearch.com/requestbrochure/hormone-replacement-therapy-market

The chapter of regional analysis in the report highlights the key factors contributing to the market growth. This involves business expansions, presence of major players in the region, favorable government policies & initiatives taken by the regional government for the market growth, and many more. It also involves the challenges faced due to import-export rules and other supply & distribution chain regulations.

To provide an all-inclusive picture of the global Hormone Replacement Therapy Market, the research analyst has obtained insights with the use of primary as well as secondary research. Primary research conducted for the research study includes interviews with industry experts through online & telephone surveys. Whereas, secondary research is conducted to get insights through company annual reports, publications, journals, articles, podcast, and webinars. All the data generated through secondary research is backed by extensive primary research.

How insights and forecasts from the reports could benefit you:

Inquire more about this report @https://www.zionmarketresearch.com/inquiry/hormone-replacement-therapy-market

What Reports Provides

Also, Research Report Examines:

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

See original here:
Global Hormone Replacement Therapy Market Technology Prospectus to 2027 Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals, Bayer AG ...

Living with ADHD while going through menopause can be challenging, but there are ways to manage both.

What do ADHD and menopause have in common other than mood changes and inattention?

Though some symptoms are observable on the outside, folks around you may not understand even half of what youre handling internally, let alone that youre managing both at the same time.

Living with attention deficit hyperactivity disorder (ADHD) comes with its own challenges. And if youre going through perimenopause or menopause, you may face more difficulties.

ADHD is a neurocognitive disorder that has three presentations:

People can receive a diagnosis early in childhood as well as late in life.

Dr. Ellen Littman, a clinical psychologist in New York state, explains that estrogen has powerful effects on brain chemistry throughout your lifetime.

Menopause is among the top biggest events to change estrogen in your body, among starting your period and becoming pregnant.

Estrogen is considered neuroprotective, in that high levels increase the availability of neurotransmitters (brain messengers) like dopamine and serotonin, which enhance cognition, mood, sleep, verbal memory, and even ADHD symptoms, Littman says, who is publishing an upcoming review article about the female hormonal effects on ADHD.

However, your levels of estrogen decline beginning in perimenopause and are spent during menopause.

While people face some symptoms off and on during menopause, Littman says those who also have ADHD experience intensified symptoms.

By understanding the relationship between menopause and increased ADHD symptoms, they are less likely to be ambushed by the amplified difficulties they experience, she says.

Both ADHD and menopause are known for patternless shifts in brain activity and hormone changes.

So, you might begin to see how overlapping symptoms happening concurrently or one after the other can worsen the experience of both conditions and make them difficult to manage.

A 2016 study even looks at the effectiveness of using ADHD medication to treat people experiencing executive function issues during menopause.

While going through menopause when you have ADHD can feel overwhelming, there are ways you can manage both conditions.

Finding a psychiatrist whos well versed and experienced in treating ADHD in people going through menopause can help you get the care you deserve.

While it might not be easy to find a psychiatrist with experience in this area, start by asking your current mental health professional or gynecologist for recommendations.

If you cant find a psychiatrist whos familiar with research demonstrating hormone involvement in ADHD symptoms, Littman suggests sharing information or articles (like this one) with them.

If you feel that your credibility is being questioned, its important to feel entitled to finding the clinician who best fits your needs, she says.

Littman suggests finding a gynecologist whos experienced in treating people going through menopause, and who will also work with the doctor who treats your ADHD.

Since women now spend about a third of their lives in menopause, it is critical to find a treatment regimen tailored to your specific needs, she says.

According to a 2019 survey of postgraduate resident trainees in family medicine, internal medicine, and obstetrics and gynecology in U.S. residency programs, only 6.8% of them reported feeling just adequately prepared to manage women experiencing menopause.

No one clinician is knowledgeable about all aspects of each individual experience, but Littman says finding doctors who will collaborate and communicate with your gynecologist can help tailor treatment.

For instance, if your ADHD medications need adjusting, as well as your decreasing estrogen levels, having both your gynecologist and doctor who treats your ADHD collaborate could help.

While pharmacologists often adjust the dosage to meet the new challenges, increased estrogen could address both menopausal and ADHD symptoms. Bioidentical hormone replacement therapy (HRT) is one route to increased estrogen for many women, Littman says.

Although your doctors may be hesitant to communicate with each other, being assertive and informing them of your conditions, as well as bringing information from each doctor to your appointments, can help ensure theyre in tune with whats going on with your body.

While theres a wide range of menopausal symptoms that occur on a continuum, Littman points out that ADHD can worsen symptoms like impaired cognition and mood.

In fact, a 2019 research paper suggests that ADHD symptoms, and even concurrent symptoms from other conditions, are also vulnerable to the hormonal changes experienced during menopause, says Littman.

Both conditions can muddle with your executive functions, a clinical term for your:

If you find that these areas of your life are becoming more difficult to manage, coming up with a plan to help navigate them can make your days easier.

For instance, if keeping and organizing appointments and commitments is difficult, setting an email calendar reminder so you get notifications on your phone, tablet, and desktop can help you stay on track.

If self-monitoring is a blind spot as of late, you could try leaning on your inner circle to gently give you a signal if agitation or strong emotions are coming off more than intended.

You might also look into present moment awareness to reconnect with mindfulness and strengthen your self-awareness.

In addition to seeing a professional, Littman suggests pursuing your own psychoeducation. Consider bookmarking the following resources:

The more you can understand about the relationship between your [brains response to ADHD] and your body in menopause, the more you can be an active participant in your treatment. And the more your support network understands about your challenges, the more supportive and compassionate they can be, Littman says.

While managing your ADHD while going through menopause can be challenging at times, there are ways to make the process easier.

Littman says that on the clinical front, new research brings hope for better treatments ahead.

Were on the brink of an exciting new understanding of the experience of women with ADHD, she says. As new studies continue to implicate the powerful role of hormones in womens experience of ADHD, the potential for more comprehensive and successful treatments may be on the horizon.

You can stay tuned for Littman and teams upcoming study on ADHD and estrogen, titled: ADHD in Females Across the Lifespan and the Role of Estrogen. It publishes August 2021 in The ADHD Report.

Go here to see the original:
Tips to Manage when You're in Menopause with ADHD - PsychCentral.com

The desire to look younger is natural

Like many other living organisms, humans are born, survive, compete for resources, reach maturity, reproduce, take care of their young, sometimes the young of their young, continuously decline, and die. Evolution needs us for just two purposes adapt and reproduce. But, unlike other species, humans are very conscious of their fate. Humans are very much aware that after reaching peak performance they will eventually grow old and die. We arevery conscious of our fate after reaching peak performance loss off function, frailty, and eventual loss of everything we worked so hard to earn.

We observe our parents, and other elderly around them, attend funerals, and understand that eventually we will get into this state. We are also very contempt with that fate as evolution made sure that. The more ambitious of us are trying to advance science, the rest seek refuge in religion, some in philosophy, some in accumulation of wealth, and some see the continuation of ourselves in our children. But despite the many technological advances transpiring in the laboratories all over the world, there is nothing we can do at this point to escape aging. There are diets, exercises, sleep, and supplements, but these provide very marginal benefits. We do not see 120+ old yoga and diet practitioners or marathon runners around. But these simple habits do help look younger longer. And many people that have very harmful habits like smoking but still diet and exercise to look younger.

Nature is also very unfair and sexist. The females lose reproductive capacity much faster then males. Most females enter menopause between 40 and 60. The average age of menopause in the US is 51. And it is very common to see the couples where the males are significantly older. And for this reason nature found its way to signal the reproductively active people that the older person is not someone they would like to copulate with. And there are many signals: graying hair, wrinkles, body composition, etc. There are few beauty contests for people over 25, and most fashion models become popular in their teenage years. Males can reproduce longer and often remain more attractive to younger females but the level of attractiveness is usually lower and often augmented by social and economic status. It also does seem like the younger women prefer older men more often then the other way around.

So looking younger is a natural desire just like it is natural to seek a younger spouse after a certain age. It is a desire to maintain reproductive viability.

And even though there are not that many aging processes that we can have any control of, the desire to look younger spurred a giant industry. Now it is technologically possible to shave a decade or even two off the way we look via cosmetic interventions, makeup, and surgery.

But whenever we see media images of older celebrities, particularly those who seem much younger than their actual age, the inevitable questions concerning whether "he/she had work done"" or snide remarks about too much botox/liposuction" are rarely far behind.

But why is there such a stigma about wanting to look younger?Despite all these often vicious remarks about cosmetic surgery and other attempts at looking young and attractive, it's not just celebrities who are doing this.While cosmetic surgery used to be reserved solely for the very rich, it is becoming much more affordable, and, not surprisingly, more people than ever are taking advantage.According to the 2019 Plastic Surgery Statistics report released by the American Society of Plastic Surgeons, more than eleven million surgical and nearly fourteen million non-surgical procedures took place worldwide last year, almost four million of those procedures in the United States alone.

Healthcare and medicine

While most cosmetic surgery patients are women,male patients are also becoming more common, and the demand for such services has steadily risen over the past decade.The primary market for women is routine procedures such as breast augmentation, rhinoplasty (nose reshaping), "tummy tucks," and dermabrasion.On the other hand,male patients are getting hair transplantation, breast reductions (or augmentation), calf and pectoral implants,penile extensions (where available), and various other improvements to make them look more masculine as well as attractive.Older clients are also getting procedures specifically intended to make them look younger and thinner, including facelifts, eyelid surgery, botox, and liposuction, to name a few highly demanded anti-aging procedures.

Cosmetic surgery has become such a growth industry that even a cursory Google search can direct would-be users to local clinics.Suppose the desired service is not available locally or cheaply. In that case, would-be customers can look into "medical tourism" involving other countries where they can get surgery and enjoy other travel perks, often in the form of all-expense-paid travel packages. Such medical tourism junkets have become a significant economic boost to otherwise economically disadvantaged countries, and the demand will undoubtedly rise as baby boomers grow older.

In many ways, though,this demand for cosmetic surgery is just the tip of the iceberg.While not everyone can afford (or are interested in) cosmetic surgery,the desire to look younger and healthier has sparked a vast anti-aging industry worldwide.Along with an astonishing number of books, videos, and courses available online offering advice on fighting the signs of age, more people than ever are seeking out various services offering the promise of looking younger and more desirable.That includes weight loss clinics, nutrition counselors, personal trainers, yoga instructors, and a host of other purveyors of youth and beauty.Many older adults seeking out these services seem to be driven by their fears about aging, not to mention unrealistic media representations about the human body (particularly the female body).

But other fears seem to be driving this need to look younger.Though laws banning age discrimination continue to pass in countries worldwide, many older adults feel compelled to hide visible signs of aging to avoid being thought of as "old." The need to look younger has sparked an entire movement surrounding the concept of "agelessness," particularly for women who are far more likely than men to be judged for their appearance.Not surprisingly, many celebrities, male and female alike, have lent their name to various anti-aging products of doubtful validity, all of which promise users the same "agelessness" they enjoy themselves (actress Suzanne Somers and her endorsement of bioidentical hormone replacement therapy, for example).

However, almost inevitably, we are now facing a backlash in the form of a "body positive" movement encouraging men, especially women, to reject what feminist researchers describe as the objectifying of physical appearance favoring a more "genuine" look.It also highlights the double standard that exists between older men and women. While older men can be considered competent regardless of their gray hair and wrinkles, recent research suggests that many women find themselves required to look younger to be accepted.Even those women who refrain from dying their hair to appear more authentic often use other beauty practices to look more youthful. Ironically, for women who choose to make themselves look younger, the most likely backlash they experience usually comes from other women rather than men, a finding recently supported by evolutionary psychology research.

But is there anything wrong with wanting to look younger and more desirable?Numerous studies show the link between perceived attractiveness, self-esteem, and subjective wellbeing.According to one study recently published in the Journal of Women and Aging, the same body dissatisfaction often seen in adolescent girls can also occur in many women as they grow older.An online survey of over three hundred women between the ages of forty-five and sixty-five found that women who were dissatisfied with their appearance and were afraid of growing older were especially prone to depression.They were also far more likely to resort to anti-aging regimens to make themselves look younger.

In another study published last year, researchers found a strong link between perceived self-attractiveness and life satisfaction in women from different age groups (825, 3045, and over 60).The study showed similar results for both overall perceived attractiveness and attractiveness of specific body parts.And people who look younger also feel younger, something that has enormous health benefits, particularly in helping people handle stress (including financial stress), cope with depression and loneliness, and greater sexual satisfaction.

Our recent work on psychological and subjective aging clocks developed using AI also provided a clue that looking younger and thinking more positively about the future correlated with lower mortality. So by looking younger you may actually live longer.

Despite the ongoing political battle over body positivity and "authenticity," wanting to look younger is very natural and certainly no cause for being stigmatized.Ultimately though, simply looking younger is not enough.we still need to invest more efforts into aging and longevity biotechnology.Helping people to live longer and more productive lives remains one of the most significant medical challenges imaginable.Also, eliminating the risk of deadly age-related conditions such as Alzheimer's disease makes research into aging an investment that will repay itself many times over.

Cosmetic procedures coupled with aging clocks may help improve the outlook on life, provide more ... [+] optimistic view on the future, extend reproductive age, and decrease mortality.

To learn more about the exciting and complex field of anti-aging research, consider attending the largest conference on aging research and drug discovery organized every year by the University of Copenhagen and Columbia University 8th Aging Research and Drug Discovery.

Link:
No Shame In Wanting To Look Younger - It Is Natural And You Might As Well Live Longer - Forbes

Linda Robson said the menopause turned her into a madwoman (Picture: ITV)

Linda Robson spoke honestly about her experiences with the menopause admitting it made her unbearable to live with.

The actress, 63, said on Thursdays Loose Women that she ended up with a low libido and began to shout at her children.

The menopause is when a woman stops having periods and is no longer able to get pregnant naturally. Symptoms can include hot flushes, vaginal dryness, difficulty sleeping or low mood.

According to the NHS, the severity of the symptoms people going through menopause will experience will vary, and symptoms often begin months or years before the menstruation stops altogether. This is known as perimenopause.

Lindas life was transformed for the better when she was on hormone replacement therapy (HRT) to help relieve the symptoms, but stopped when her sister was battling cancer, which led to her feeling even worse.

She told panelists Charlene White, Brenda Edwards and Nadia Sawalha: I knew I was going through the menopause because my sister went through it at 38 and I started getting all the symptoms, hot sweats, and no one can understand what a hot sweat is until youve had one.

You think its like a flash but its not. It actually goes through your whole body. It goes up through your back, over your head, all your make-ups gone.

She went on: Ive always had quite a high libido and all of a sudden I had no libido and I turned into a mad woman. I was shouting at the kids all the time, at my husband and everything.

So I decided to try the HRT and it just changed my life. But then my sister got breast cancer so me and my other sister came off of HRT. Its the worst Ive ever been.

Nadia interjected: I think that was the beginning of you going downhill.

Linda agreed: I was always quite happy, breezy, and all of a sudden I was a monster. The kids were going to me, Mum youve gotta go back on HRT and as soon as I went back on it my life changed again. My libidos through the roof!

Typically menopause comes on between the ages of 45 and 55, with the average age being 51.

Nadia urged people to speak to someone if any of their discussion resonated with them.

Loose Women airs weekdays from 12.30pm on ITV.

Got a story?

If youve got a celebrity story, video or pictures get in touch with the Metro.co.uk entertainment team by emailing us celebtips@metro.co.uk, calling 020 3615 2145 or by visiting our Submit Stuff page wed love to hear from you.

MORE : Space Jam: A New Legacy review: Star-studded LeBron James reboot is not slam dunk

MORE : Never Have I Ever season 2: Gigi Hadid replaces Chrissy Teigen as Paxtons narrator in Netflix comedy series

Read the original here:
Linda Robson says struggle with menopause turned her into a monster - Metro

Navan plans to focus on enhancing diversity and inclusion within the AAJ.

ATLANTA (July 14, 2021) Beasley Allens Navan Ward was installed as the 75th president of the American Association for Justice today during the groups annual meeting. He is the second minority to hold the position, with the first being more than two decades ago. It is this area of representation that Ward and other AAJ leaders are working to improve on in the future and is central to Wards goals for his administration.

I am thankful for my experience at Beasley Allen, where our leadership fosters a culture of inclusion and values the unique backgrounds, experiences and personal achievements of minority lawyers, Ward said. The firm has been recognized for its focus on diversity among its lawyers, including by Law360 as one of the 10 Best Law Firms for Black Attorneys in the U.S and previously recognized as the #1 law firm with African American partners. It is an approach we want to nurture in firms nationwide, Ward said.

The AAJ leadership understands that leaders from diverse backgrounds can strengthen and empower each other and those they lead. Navan has worked with AAJ leadership to recruit, train, and encourage members from different backgrounds (including race, gender, age, geography, and level of career) to become active leaders.

On many different levels and across various landscapes, our country is rebuilding, so it is the perfect time to do the same within the American Association for Justice. The AAJ is an organization that advocates for access to justice and works to preserve the rights given by the 7th Amendment of the U.S. Constitution. It is important that the organization genuinely reflects the diversity that makes it great. I look forward to implementing strategies that will build on the work of the past presidents and strengthen our leadership moving forward, Ward said.

Ward launched what has become the cornerstone of these efforts in 2012 called the American Association for Justice Diversity and Inclusion Leadership Academy. The Leadership Academy trains highly qualified and talented AAJ members, particularly those underrepresented within the association, to help them become more effective leaders. Graduates are encouraged to participate in leadership opportunities throughout AAJ, including the six-to-seven-year national officer track. The Leadership Academy provides leadership and benefits from continued training and leadership development. It is one way the organization guarantees the retention of minority leaders who can ensure underrepresented member groups have a voice in the future of the AAJ.

Ward is the firms lead attorney on the metal-on-metal hip implant litigation and proton pump inhibitor (PPI) litigation and practices from the Atlanta office. Currently, he serves on the Plaintiffs Steering Committee (PSC) for the DePuy ASR Hip Implant Recall Multi-District Litigation (MDL), DePuy Pinnacle Hip Implant MDL and was appointed as co-lead counsel for the Plaintiffs Executive Committee (PEC) in the Biomet M2a Magnum Hip Implant Products Liability MDL. Ward has been instrumental in assisting with the verdicts and global settlements against major hip implant manufacturers, including Johnson & Johnson / DePuy for $4.057 billion, Howmedica Osteonics Corporation / Stryker for over $1 billion, and Biomet Corporation for more than $250 million, and additional confidential settlements involving other metal-on-metal or modular-neck hip components. Ward has also been appointed to the PEC for the PPI MDL.

Before his work on PPI and hip implant litigation, Ward was heavily involved with the hormone replacement therapy litigation, representing hundreds of women diagnosed with breast cancer due to ingesting these combination hormone medications. His trial team was responsible for obtaining a $72.6 million verdict for three hormone therapy clients that went to trial. Ward was also responsible for overseeing the Meridia pharmaceutical drug litigation. This medication caused heart attacks and strokes and was heavily involved with the Cox-2 (Vioxx, Celebrex and Bextra) pharmaceutical drug litigation. His practice has also handled personal injury and wrongful death cases, including those involving nursing home abuse and neglect and trucking crashes. Overall, Ward has obtained more than $360 million for the specific clients that he has represented in the various areas he has practiced.

For his efforts in representing clients, Beasley Allen awarded him as the firms Litigator of the Year in 2013 and Mass Torts Litigator of the Year in 2011 and 2014.

In 2017, Ward received the AAJ Minority Caucus Stalwart Award for his dedicated years of service to the Minority Caucus and the organization overall. It also awarded him the AAJ Distinguished Service Award in 2012 and 2015 and its Wiedemann & Wysocki Award in 2014. Ward has been regularly selected to the Best Lawyers in America list, the Super Lawyers list, and named to the LawDragon 500 Leading Plaintiff Consumer Lawyers, the 500 best attorneys across the nation in this category.

Ward previously served in other AAJ leadership positions, including a past chairman of the Minority Caucus, past chairman of the Diversity Committee, and a member of the Board of Governors. He is a former Alabama State Bar delegate for the American Bar Association, past president of the Alabama Lawyers Association, the Alabama State Bars Young Lawyers Section, and the Montgomery County Association for Justice. Ward was a member of Leadership Montgomerys Class XXI, a former chairman of the Father Walters Charity Golf Tournament, and a member of the Alabama Law Foundation Grant Committee.

About Beasley Allen Law Firm

Founded in 1979, Beasley Allen Law Firm is a leader in complex plaintiff litigation nationwide. We work with attorneys and clients nationwide and have offices located in Atlanta, Georgia, Montgomery, Alabama, and Mobile, Alabama.Our award-winning attorneys live by our creed of helping those who need it most. For more information about our firm, please visit us online at http://www.beasleyallen.com.

Originally posted here:
Beasley Allen's Navan Ward Installed as the American Association of Justice 75th President - Montgomery Independent